MedTrace Logo

National Cardiogenic Shock Initiative

NCT03677180 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 406

Last updated 2025-07-01

Study results available
· View outcomes & findings →

Summary

This study evaluates the use of early mechanical circulatory support in patients presenting with acute myocardial infarction and cardiogenic shock. Patients are treated according to the National Cardiogenic Shock Initiative protocol, which emphasizes early identification of cardiogenic shock and rapid delivery of mechanical circulatory support based on invasive hemodynamics. All patients treated in this manner are enrolled in the National Cardiogenic Shock registry.

Conditions

  • Cardiogenic Shock
  • Acute Myocardial Infarction
  • STEMI - ST Elevation Myocardial Infarction
  • NSTEMI - Non-ST Segment Elevation MI
  • Heart Attack

Sponsors & Collaborators

  • Abiomed Inc.

    collaborator INDUSTRY

  • Chiesi Farmaceutici S.p.A.

    collaborator INDUSTRY

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • William W O'Neill, MD · Henry Ford Health System

  • Babar Basir, DO · Henry Ford Health System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-19
Primary Completion
2020-12-01
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03677180 on ClinicalTrials.gov